Stephen Mayo - 16 Nov 2021 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Stephen L. Mayo
Issuer symbol
SRPT
Transactions as of
16 Nov 2021
Net transactions value
$0
Form type
4
Filing time
17 Nov 2021, 19:06:35 UTC
Previous filing
02 Jun 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award $0 +4,292 $0.000000 4,292 16 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Award $0 +8,238 $0.000000 8,238 16 Nov 2021 Common Stock 8,238 $83.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning November 16, 2022.
F2 The option vests in three equal annual installments beginning November 16, 2022.